Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 06, 2022
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab.
Journal: Cancer immunology research
Published: August 11, 2015
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 20, 2014
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 23, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026